Greer Provides Extract For Duke University Medical Center Study Evaluating Sublingual-Oral Immunotherapy For Peanut Allergies

LENOIR, N.C.--(BUSINESS WIRE)--Greer, a leading developer and provider of allergy immunotherapy products and source materials, is providing peanut extract to Duke University Medical Center for their sublingual-oral immunotherapy study. The study is designed to evaluate whether sublingual-oral immunotherapy with an extract from raw peanut source materials is a safe and effective treatment for children and adults with peanut allergies. Wesley Burks (http://www.dukemednews.org/experts/detail.php?id=352), M.D., chief of the division of pediatric allergy and immunology at Duke University Medical Center, is the principle investigator for the study which is being funded through a grant from the National Institutes of Health.